Hematological malignancies (leukemia, lymphoma, multiple myeloma, etc.)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Diagnosed with hematological malignancies (leukemia, lymphoma, multiple myeloma, etc.) and have completed hematopoietic stem cell transplantation (HSCT); 2.Aged 18 years or older, with intact verbal expression and comprehension abilities to complete the interview independently; 3.Voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.With cognitive, psychiatric or language disorders that impede normal communication; 2.Critically ill or physically debilitated, unable to tolerate the interview; 3.Critically ill or physically debilitated, unable to tolerate the interview; 4.Participating in other similar qualitative studies for patients concurrently.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Full-cycle treatment decision-making experience, stage-specific needs and barriers of patients with hematological malignancies undergoing hematopoietic stem cell transplantation; | — |
Countries
China
Contacts
The Affiliated Hospital of Southwest Medical University